Applications & Products
Applications
Products
Media Formulation
About InVitria
News & Blog
Contact Us
Terms
Privacy
Sitemap
Performance.
Defined.
1-800-916-8311
or
Email Us
My Account
View Cart
Applications & Products
Applications
Gene Therapy
Cell Therapy
T-Cell Immunotherapy
Vaccine Production
Antibody Production
Final Formulation
Food Science
Product Types
Blood-Free Cell Culture Media
Cell Culture Components
Insulin-Transferrin Supplements
Recombinant Albumin
Recombinant Transferrin
Recombinant Lysozyme
Products
Cellastim S – Recombinant human albumin
Exbumin
®
– Recombinant human albumin excipient
Optibumin – Recombinant human albumin
Optiferrin – Recombinant human transferrin
Lacromin – Recombinant human holo lactoferrin
ITS AF – Blood-free cell culture media supplement
ITSE + A – Blood-free cell culture media supplement
ITSE Animal-Free
®
– Blood-free cell culture media supplement
Lysobac – Recombinant human lysozyme
Leukemia Inhibitory Factor
OptiVERO
®
Media Formulation
About InVitria
News & Blog
Contact Us
Applications
Products
Contact Us
Menu toggle
Search
Home
Accelerating Vaccine Development Through Use of Blood-Free Components
Accelerating Vaccine Development Through Use of Blood-Free Components
Published on 1 February 2021
Presented by Genetic Engineering & Biotechnology News on 26 January 2021
Start New Search
